Search by Drug Name or NDC
NDC 60505-0826-01 Ipratropium Bromide 21 ug/1 Details
Ipratropium Bromide 21 ug/1
Ipratropium Bromide is a NASAL SPRAY, METERED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is IPRATROPIUM BROMIDE.
MedlinePlus Drug Summary
Ipratropium nasal spray is available in two strengths that are used to treat different conditions. Ipratropium nasal spray 0.06% is used to relieve a runny nose caused by the common cold or seasonal allergies (hay fever) in adults and children age 5 and older. Ipratropium nasal spray 0.03% is used to relieve a runny nose caused by year-round allergic and nonallergic rhinitis (runny nose and stuffiness) in adults and children age 6 and older. Ipratropium nasal spray does not relieve nasal congestion, sneezing, or postnasal drip caused by these conditions. Ipratropium nasal spray is in a class of medications called anticholinergics. It works by reducing the amount of mucus produced in the nose.
Related Packages: 60505-0826-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ipratropium Nasal Spray
Product Information
| NDC | 60505-0826 |
|---|---|
| Product ID | 60505-0826_5817f135-603d-97c9-6076-2aa22ab6bf26 |
| Associated GPIs | 42300040102010 |
| GCN Sequence Number | 024457 |
| GCN Sequence Number Description | ipratropium bromide SPRAY 21 MCG NASAL |
| HIC3 | Q7A |
| HIC3 Description | NOSE PREPARATIONS, MISCELLANEOUS (RX) |
| GCN | 42239 |
| HICL Sequence Number | 000057 |
| HICL Sequence Number Description | IPRATROPIUM BROMIDE |
| Brand/Generic | Generic |
| Proprietary Name | Ipratropium Bromide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ipratropium Bromide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SPRAY, METERED |
| Route | NASAL |
| Active Ingredient Strength | 21 |
| Active Ingredient Units | ug/1 |
| Substance Name | IPRATROPIUM BROMIDE |
| Labeler Name | Apotex Corp. |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA076156 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 60505-0826-01 (60505082601)
| NDC Package Code | 60505-0826-1 |
|---|---|
| Billing NDC | 60505082601 |
| Package | 1 BOTTLE, SPRAY in 1 CARTON (60505-0826-1) / 345 SPRAY, METERED in 1 BOTTLE, SPRAY |
| Marketing Start Date | 2020-05-26 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.70125 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | IPRATROPIUM 0.03% SPRAY |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |